#Efficacy

Stephen V Liu

StephenVLiu

#OncoAlert Results from the phase III TAHOE trial now available @JTOonline - compared 2L rovalpituzumab-teserine (Rova-T) versus topotecan in DLL3-high #SCLC. Stopped early for futility, not meeting its OS endpoint.

Peter Kolchinsky

PeterKolchinsky

New data from Novavax vaccine just showed that UK & esp South African variants are more problematic in real world than lab experiments suggested. Implications are profound for 2021 and

Lucy Walker Lab UCL

LucyWalkerlab

Protection does not wane 3 months post vaccination with 1 dose of the AZ/Ox vaccine. 1 dose provided 76% protection against symptomatic #COVID19 in the first 90 days after vaccination

A Marm Kilpatrick

DiseaseEcology

Will vaccination reduce transmission or just disease?Do 3 vaccines w interim or final phase 3 results (Pfizer, Astrazeneca, Moderna) reduce asymptomatic infections & does reduced symptomatic infection imply reduced infections?Thread

Youyang Gu

youyanggu

The recent focus on reaching herd immunity through vaccination may be overblown.My modeling suggests that it is increasingly unlikely that the US will reach the immunity levels required for theoretical

Dr David Berger #CovidIsAirborne STOP KILLING HCWs

YouAreLobbyLud

1/ Australian Academy of Science Press Release at 20.40 on Jan 14th"statement on the pandemic, vaccines and misinformation"A 'suck-up to government', incorrect press release. I'll show you how @Science_Academy itself

Ian Lyne

lyne_ian

Thread.Face masks.Starting with Epidemiologist, Biostatician and Public Health Physician @simonthornley30 Please retweet . . Continued . . . Primary Doctor Medical JournalA peer-reviewed journal by physicians and scientists without commerci

Geoff Brumfiel

gbrumfiel

A lot of people are tweeting about how this new Pfizer vaccine finding has not been peer-reviewed. That's true, but it's also important to understand that academic peer-review is not

SirtSix

SirtSix

Two papers out from $REGN in @ScienceMagazine describing the company's investigational antibody cocktail approach to protect against #COVID19. Paper 1 describes pairs of highly potent (pM neutralization potency) non-competing mAbs

Heiner Prahm

heinerprahm

Part1 - Very Urgent Message to Prime Minister Boris Johnson from Dr. Tess Lawrie - Director of The Evidence-Based Medicine Consultancy Ltd"The good news is that we now have solid

Kim Cavill

sexposparenting

It's Sunday, so that means it's sex ed question box time where I answer five anonymous questions young people have asked me in classes over the past few years: Q:

Lucy Walker Lab UCL

LucyWalkerlab

This thread pulls together some of the information underpinning the decision to delay the 2nd dose of COVID19 vaccine. The brief statement from the Joint Committee on Vaccination and Immunisation

Hilda Bastian, PhD

hildabast

Statement from the UK Joint Committee on Vaccination & Immunisation (JCVI) on why they believe their strategy will achieve maximum impact: https://app.box.com/s/uwwn2dv4o2d0ena726gf4403f3p2acnu 1/n ...They point out that most of the

Psyber Attack

PsyberAttack

This is good news, but Brits may be reading too much into it. I've been eyebleeding it and the impact seems pronounced after the 2nd dose, (looking at the 40-60

David Laing

davidklaing

There are lots of great resources that help data scientists land their first job, or learn about specific subjects. But I haven't seen any that focus on long-term professional development.

zeynep tufekci

zeynep

The BioNTech/Pfizer data is out—NEJM & FDA report. I understand this wasn't in the design & the long-term protection from single dose is open question. But given this sharp drop

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.